North Carolina, U.S.A. - Swiss Pharmaceutical business, Octapharma AG, an independent global plasma fractionator specializing in human proteins, announced today the expansion of its U.S. subsidiary, Octapharma Plasma, Inc. Octapharma Plasma will relocate to a state-of-the-art facility in Westlake Business Park, investing $39.2 million. Construction on the facility is slated to be complete mid-2014. The Charlotte expansion strategically positions Octapharma Plasma to service the U.S. market from one central location.
“We are extremely excited to expand our U.S. operations here in Charlotte with this state-of-the-art facility. The corporate office relocated to Charlotte in October 2009, and this step is a natural progression in our strategic planning of building Octapharma’s global business. The Charlotte workforce consists of skilled professionals, and we will be creating 45 new full-time positions, valuable in our mission to provide quality plasma products to our customers,” said Frederic Marguerre, president of Octapharma Plasma, Inc.
Octapharma Plasma, Inc. owns and operates plasma collection centers throughout the United States that are critical to the development of life-saving patient therapies utilized by thousands of patients worldwide.
Octapharma Plasma is a subsidiary of one of the world’s largest plasma products manufacturers, Octapharma AG. Headquartered in Lachen, Switzerland, Octapharma has been committed to patient care and medical innovation for 30 years. Octapharma’s core business is the development and production of human proteins from human plasma and human cell lines. Patients in more than 100 countries are treated with products in the following therapeutic areas: hematology (coagulation disorders); immunotherapy (immune disorders); and intensive care and emergency medicine. Octapharma owns five production facilities in Austria, France, Germany, Sweden and Mexico.
The Charlotte Chamber would like to thank the North Carolina Department of Commerce, Mecklenburg County and the city of Charlotte for assisting with the site selection process.